Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Anemia

  Free Subscription


Articles published in Hemoglobin

Retrieve available abstracts of 143 articles:
HTML format
Text format



Single Articles


    October 2018
  1. PU J, Zhang L, Wei X, Xu X, et al
    Clinical Genotyping by Next Generation Sequencing Reveals a Novel, De Novo beta-Globin Gene Mutation Causing Hemolytic Anemia in a Chinese Individual.
    Hemoglobin. 2018 Oct 2:1-5. doi: 10.1080/03630269.2018.1496928.
    PubMed     Text format     Abstract available


    July 2018
  2. ALAUDDIN H, Kamarudin K, Loong TY, Azma RZ, et al
    A Unique Interaction of IVS-I-1 (G>A) (HBA2: c.95+1G>A) with Hb Adana (HBA2: c.179G>A) Presenting as Transfusion-Dependent alpha-Thalassemia.
    Hemoglobin. 2018;42:247-251.
    PubMed     Text format     Abstract available


  3. SARGOLZAIE N, Montazer Zohour M, Ayubi E, Shahraki F, et al
    Relationship Between Social Determinants of Health and the Thalassemia Prenatal Diagnosis Test in Zahedan, South Eastern Iran.
    Hemoglobin. 2018;42:231-235.
    PubMed     Text format     Abstract available


  4. DASH PM, Sahu PK, Patel S, Mashon RS, et al
    Effect of Assorted Globin Haplotypes and alpha-Thalassemia on the Clinical Heterogeneity of Hb S-beta-Thalassemia.
    Hemoglobin. 2018;42:236-242.
    PubMed     Text format     Abstract available


    May 2018
  5. XU C, Liao B, Qi Y, Huangfu Z, et al
    Analysis of Gene Mutation Types of alpha- and beta-Thalassemia in Fuzhou, Fujian Province in China.
    Hemoglobin. 2018;42:143-147.
    PubMed     Text format     Abstract available


  6. BARBERO U, Fornari F, Guarguagli S, Gaglioti CM, et al
    Atrial fibrillation in beta-thalassemia Major Patients: Diagnosis, Management and Therapeutic Options.
    Hemoglobin. 2018;42:189-193.
    PubMed     Text format     Abstract available


  7. CHEN JK, Xin XQ, Huang JG
    A Novel beta-Thalassemia Mutation in a Chinese family: IVS-II-203-205 (TCT>CC) (HBB: c.315+203TCT>CC).
    Hemoglobin. 2018;42:159-160.
    PubMed     Text format     Abstract available


  8. JIANG F, Qu YX, Chen GL, Li J, et al
    KFL1 Gene Variants in alpha-Thalassemia Individuals with Increased Fetal Hemoglobin in a Chinese Population.
    Hemoglobin. 2018;42:161-165.
    PubMed     Text format     Abstract available


  9. CHOMEAN S, Pholyiam K, Thamwarokun A, Kaset C, et al
    Development of Visual Detection of alpha-Thalassemia-1 (the - -(SEA) Deletion) Using pH-Sensitive Loop-Mediated Isothermal Amplification.
    Hemoglobin. 2018;42:171-177.
    PubMed     Text format     Abstract available


  10. MOASSAS F, Alabloog A, Murad H
    Description of a Rare beta-Globin Gene Mutation: -86 (C>G) (HBB: c.-136C>G) Observed in a Syrian Family.
    Hemoglobin. 2018;42:203-205.
    PubMed     Text format     Abstract available


    April 2018
  11. GODBOLE KG, Ramachandran A, Karkamkar AS, Dalal AB, et al
    Compound Heterozygosity for Hb Alperton (HBB: c.407C>T) and IVS-I-5 (G>C) (HBB: c.92+5G>C) Mutations Presenting as a Moderate Anemia in an Indian Family.
    Hemoglobin. 2018 Apr 13:1-2. doi: 10.1080/03630269.2018.1450754.
    PubMed     Text format     Abstract available


    March 2018
  12. MELLA F, Yamashiro Y, Adhiyanto C, Tanaka T, et al
    A Coincidental Discovery of a New Stable Variant (Hb Hachioji or HBB: c.187C>T) in a Patient with Chronic Hemolytic Anemia of Unexplained Origin.
    Hemoglobin. 2018 Mar 7:1-6. doi: 10.1080/03630269.2018.1429279.
    PubMed     Text format     Abstract available


  13. JHA AN, Mishra H, Verma HK, Pandey I, et al
    Compound Heterozygosity of beta-Thalassemia and the Sickle Cell Hemoglobin in Various Populations of Chhattisgarh State, India.
    Hemoglobin. 2018;42:84-90.
    PubMed     Text format     Abstract available


  14. KHAN NM, Rehman SU, Shakeel M, Khan S, et al
    Molecular Characterization of beta-Thalassemia Mutations Via the Amplification Refractory Mutation System-Polymerase Chain Reaction Method at the North Waziristan Agency, Pakistan.
    Hemoglobin. 2018;42:91-95.
    PubMed     Text format     Abstract available


  15. BELHAJ NEFISSI R, Doggui R, Ouali F, Messaoud T, et al
    Factor V Leiden G1691A, Prothrombin G20210A, and MTHFR C677T and A1298C Mutations in Patients With Sickle Cell Disease in Tunisia.
    Hemoglobin. 2018;42:96-102.
    PubMed     Text format     Abstract available


  16. LISTI F, Sclafani S, Agrigento V, Barone R, et al
    Study on the Role of Polymorphisms of the SOX-6 and MYB Genes and Fetal Hemoglobin Levels in Sicilian Patients with beta-Thalassemia and Sickle Cell Disease.
    Hemoglobin. 2018;42:103-107.
    PubMed     Text format     Abstract available


  17. BAYHAN T, Unal S, Konuskan B, Erdem O, et al
    Assessment of Peripheral Neuropathy in Patients with beta-Thalassemia via Electrophysiological Study: Reevaluation in the Era of Iron Chelators.
    Hemoglobin. 2018;42:113-116.
    PubMed     Text format     Abstract available


  18. VAN DE WATER N, Tan T, Crowley M, Kerr R, et al
    Novel alpha-Globin Splice Site Mutation (HBA2: c.96-5C>A) in Combination with Three-Gene Deletion Hb H Disease.
    Hemoglobin. 2018;42:122-125.
    PubMed     Text format     Abstract available


  19. GRIMHOLT RM, Harteveld CL, Arkesteijn SGJ, Fjeld B, et al
    Characterization of Two Deep Intronic Variants on the beta-Globin Gene with Inconsistent Interpretations of Clinical Significance.
    Hemoglobin. 2018;42:126-128.
    PubMed     Text format     Abstract available


  20. GRIMHOLT RM, Vestli A, Urdal P, Bechensteen AG, et al
    Hb Oslo [beta42(CD1)Phe-->Ile; HBB: c.127T>A]: A Novel Unstable Hemoglobin Variant Found in a Norwegian Patient.
    Hemoglobin. 2018;42:78-83.
    PubMed     Text format     Abstract available


  21. ZHAO P, Weng R, Wu H
    Molecular Spectrum of alpha- and beta-Thalassemia Mutations in a Large Ethnic Hakka Population in Southern China.
    Hemoglobin. 2018;42:117-121.
    PubMed     Text format     Abstract available


  22. THEODORIDOU S, Teli A, Yfanti E, Vyzantiadis TA, et al
    Compound Heterozygosity for Hb Adana (HBA2: c.179G>A) and the -alpha(3.7)/alphaalpha Thalassemia Deletion in Greece: Clinical Phenotype and Genetic Counseling.
    Hemoglobin. 2018;42:129-131.
    PubMed     Text format     Abstract available


  23. ARDUINI GAO, Trovo de Marqui AB
    Prevalence and Characteristics of Priapism in Sickle Cell Disease.
    Hemoglobin. 2018;42:73-77.
    PubMed     Text format     Abstract available


  24. NICKARIA S, Haghpanah S, Ramzi M, Karimi M, et al
    Relationship of the Interaction Between Two Quantitative Trait Loci with gamma-Globin Expression in beta-Thalassemia Intermedia Patients.
    Hemoglobin. 2018;42:108-112.
    PubMed     Text format     Abstract available


  25. DANA M, Fibach E
    Fetal Hemoglobin in the Maternal Circulation - Contribution of Fetal Red Blood Cells.
    Hemoglobin. 2018;42:138-140.
    PubMed     Text format     Abstract available


  26. TANG HS, Wang DG, Huang LY, Li DZ, et al
    delta-Thalassemia with Complete Absence of Hb A2 in a Chinese Family.
    Hemoglobin. 2018;42:135-137.
    PubMed     Text format     Abstract available


  27. SUN M, Lou J, Zhao Y, Liu Y, et al
    Molecular and Hematological Characterization of Two Novel delta-Globin Gene Mutations Found in Chinese Individuals.
    Hemoglobin. 2018;42:132-134.
    PubMed     Text format     Abstract available


    January 2018
  28. SEWARALTHAHAB SS, Menaker J, Law JY
    Successful Use of Veno-Venous Extracorporeal Membrane Oxygenation in an Adult Patient with Sickle Cell Anemia and Severe Acute Chest Syndrome.
    Hemoglobin. 2018;42:65-67.
    PubMed     Text format     Abstract available


  29. MANCUSO L, Vitrano A, Mancuso A, Sacco M, et al
    Left Ventricular Diastolic Dysfunction in beta-Thalassemia Major with Heart Failure.
    Hemoglobin. 2018;42:68-71.
    PubMed     Text format     Abstract available


  30. GHABER SM, Trabelsi N, Salem ML, Haddad F, et al
    Hb Moscva [beta24(B6)Gly-->Asp (GGT>GAT), HBB: c.74G>A]: An Unstable Hemoglobin Newly Detected as a De Novo Mutation in a Mauritanian Patient.
    Hemoglobin. 2018;42:7-10.
    PubMed     Text format     Abstract available


  31. VOSPER J, Evangeli M, Porter JB, Shah F, et al
    Psychological Factors Associated with Episodic Chelation Adherence in Thalassemia.
    Hemoglobin. 2018;42:30-36.
    PubMed     Text format     Abstract available


  32. HE S, Li J, Huang P, Zhang S, et al
    Characterization of Hb Bart's Hydrops Fetalis Caused by - -(SEA) and a Large Novel alpha(0)-Thalassemia Deletion.
    Hemoglobin. 2018;42:61-64.
    PubMed     Text format     Abstract available


  33. VO LTT, Nguyen TT, Le HX, Le HTT, et al
    Analysis of Common beta-Thalassemia Mutations in North Vietnam.
    Hemoglobin. 2018;42:16-22.
    PubMed     Text format     Abstract available


  34. MOUKHADDER HM, Roumi JE, Bou-Fakhredin R, Taher AT, et al
    Hepatocellular Carcinoma in a beta-Thalassemia Intermedia Patient: Yet Another Case in the Expanding Epidemic.
    Hemoglobin. 2018;42:58-60.
    PubMed     Text format     Abstract available


  35. PANG W, Long J, Weng X, Fan Q, et al
    Identification of Three Types of alpha-Thalassemia Deletion, -alpha(21.9), -alpha(2.4), and - -(THAI), and Their Frequencies, in One Family in the Population of Southern Guangxi Zhuang Autonomous Region, People's Republic of China.
    Hemoglobin. 2018;42:37-42.
    PubMed     Text format     Abstract available


  36. UPADHYE D, Das RS, Ray J, Acharjee S, et al
    Newborn Screening for Hemoglobinopathies and Red Cell Enzymopathies in Tripura State: A Malaria-Endemic State in Northeast India.
    Hemoglobin. 2018;42:43-46.
    PubMed     Text format     Abstract available


    November 2017
  37. RIZK S, Pulte ED, Axelrod D, Ballas SK, et al
    Perinatal Maternal Mortality in Sickle Cell Anemia: Two Case Reports and Review of the Literature.
    Hemoglobin. 2017 Nov 28:1-5. doi: 10.1080/03630269.2017.1397017.
    PubMed     Text format     Abstract available


    July 2017
  38. KANDHRO AH, Prachayasittikul V, Isarankura Na-Ayudhya C, Nuchnoi P, et al
    Prevalence of Thalassemia Traits and Iron Deficiency Anemia in Sindh, Pakistan.
    Hemoglobin. 2017 Jul 26:1-7. doi: 10.1080/03630269.2017.1345759.
    PubMed     Text format     Abstract available


  39. PEDROSO GA, Kimura EM, Santos MNN, Albuquerque DM, et al
    Coinheritance of Hb Bristol-Alesha [beta67(E11)Val-->Met; HBB: c.202G>A] and the alpha212 Patchwork Allele in a Brazilian Child with Severe Congenital Hemolytic Anemia.
    Hemoglobin. 2017 Jul 3:1-6. doi: 10.1080/03630269.2017.1340305.
    PubMed     Text format     Abstract available


    June 2017
  40. PORNPRASERT S, Thongsat C, Panyachadporn U
    Evaluation of Applying a Combination of Red Cell Indexes and Formulas to Differentiate beta-Thalassemia Trait from Iron Deficiency Anemia in the Thai Population.
    Hemoglobin. 2017 Jun 9:1-4. doi: 10.1080/03630269.2017.1323763.
    PubMed     Text format     Abstract available


    April 2017
  41. WAH ST, Yi YS, Khin AA, Plabplueng C, et al
    Prevalence of Anemia and Hemoglobin Disorders Among School Children in Myanmar.
    Hemoglobin. 2017 Apr 2:1-6. doi: 10.1080/03630269.2017.1289103.
    PubMed     Text format     Abstract available


    March 2017
  42. D'AMBROSIO R, Maggioni M, Donato MF, Lampertico P, et al
    Decompensated Cirrhosis and Sickle Cell Disease: Case Reports and Review of the Literature.
    Hemoglobin. 2017;41:131-133.
    PubMed     Text format     Abstract available


  43. HOJJATI MT, Azarkeivan A, Pourfathollah AA, Amirizadeh N, et al
    Comparison of MicroRNAs Mediated in Reactivation of the gamma-Globin in beta-Thalassemia Patients, Responders and Non-Responders to Hydroxyurea.
    Hemoglobin. 2017;41:110-115.
    PubMed     Text format     Abstract available


  44. DORO MG, Casu G, Frogheri L, Persico I, et al
    Molecular Characterization of beta-Thalassemia Mutations in Central Vietnam.
    Hemoglobin. 2017;41:96-99.
    PubMed     Text format     Abstract available


  45. GUEYE TALL F, Martin C, Malick Ndour EH, Deme Ly I, et al
    Genetic Background of the Sickle Cell Disease Pediatric Population of Dakar, Senegal, and Characterization of a Novel Frameshift beta-Thalassemia Mutation [HBB: c.265_266del; p.Leu89Glufs*2].
    Hemoglobin. 2017;41:89-95.
    PubMed     Text format     Abstract available


  46. GHOTI H, Fibach E, Rachmilewitz EA, Jeadi H, et al
    New Insights on beta-Thalassemia in the Palestinian Population of Gaza: High Frequency and Milder Phenotype Among Homozygous IVS-I-1 (HBB: c.92+1G>A) Patients with High Levels of Hb F.
    Hemoglobin. 2017;41:144-146.
    PubMed     Text format     Abstract available


  47. HUSSAIN A, Ahmed S, Ali N, S Mailk H, et al
    Rare beta-Globin Gene Mutations in Pakistan.
    Hemoglobin. 2017;41:100-103.
    PubMed     Text format     Abstract available


  48. MUHAMMAD R, Shakeel M, Rehman SU, Lodhi MA, et al
    Population-Based Genetic Study of beta-Thalassemia Mutations in Mardan Division, Khyber Pakhtunkhwa Province, Pakistan.
    Hemoglobin. 2017;41:104-109.
    PubMed     Text format     Abstract available


  49. BUCAK IH, Almis H, Benli S, Turgut M, et al
    The Assessment of Skin Color and Iron Levels in Pediatric Patients with beta-Thalassemia Major Using a Visual Skin Color Chart.
    Hemoglobin. 2017;41:120-123.
    PubMed     Text format     Abstract available


  50. NWEGBU MM, Isa HA, Nwankwo BB, Okeke CC, et al
    Preliminary Evaluation of a Point-of-Care Testing Device (SickleSCAN) in Screening for Sickle Cell Disease.
    Hemoglobin. 2017;41:77-82.
    PubMed     Text format     Abstract available


  51. BASHA B, Mularo F, Cook JR
    Design, Validation, and Clinical Implementation of a Gap-Polymerase Chain Reaction Method for alpha-Thalassemia Genotyping Using Capillary Electrophoresis.
    Hemoglobin. 2017;41:124-130.
    PubMed     Text format     Abstract available


  52. HADDAD F, Trabelsi N, Chaouch L, Darragi I, et al
    Homozygous Mutation on the beta-Globin Polyadenylation Signal in a Tunisian Patient with beta-Thalassemia Intermedia and Coinheritance of Gilbert's Syndrome.
    Hemoglobin. 2017;41:147-150.
    PubMed     Text format     Abstract available


  53. LIU J, Huang Y, Lei Y, Lai Y, et al
    Hb Southampton [beta106(G8)Leu-->Pro; HBB: c.320T>C] and Codons 41/42 (-TTCT; HBB: c.124_127delTTCT) in a Chinese Girl.
    Hemoglobin. 2017;41:134-136.
    PubMed     Text format     Abstract available


    January 2017
  54. AZIMI A, Alibakhshi R, Hayati H, Tahmasebi S, et al
    IVS-II-648/649 (-T) (HBB: c.316-202del) Triggers a Novel beta-Thalassemia Phenotype.
    Hemoglobin. 2017;41:44-46.
    PubMed     Text format     Abstract available


  55. HE S, Qin Q, Lin L, Chen Q, et al
    Complex Interaction of Hb Q-Thailand with alpha0- and beta0-Thalassemia in a Chinese Family.
    Hemoglobin. 2017;41:68-72.
    PubMed     Text format     Abstract available


  56. JIANG F, Huang LY, Chen GL, Zhou JY, et al
    A Novel Frameshift Mutation at Codons 138/139 (HBB: c.417_418insT) on the beta-Globin Gene Leads to beta-Thalassemia.
    Hemoglobin. 2017;41:59-60.
    PubMed     Text format     Abstract available


  57. ADAM S, Afifi H, Thomas M, Magdy P, et al
    Quality of Life Outcomes in a Pediatric Thalassemia Population in Egypt.
    Hemoglobin. 2017;41:16-20.
    PubMed     Text format     Abstract available


  58. LECKNGAM P, Limweeraprajak E, Kiewkarnkha T, Tatu T, et al
    The Hb E (HBB: c.79G>A), Mean Corpuscular Volume, Mean Corpuscular Hemoglobin Cutoff Points in Double Heterozygous Hb E/- -SEA alpha-Thalassemia-1 Carriers are Dependent on Hemoglobin Levels.
    Hemoglobin. 2017;41:38-43.
    PubMed     Text format     Abstract available


  59. CHEN B, Lin L, Yi S, Chen Q, et al
    A Novel Mutation of the alpha2-Globin Gene Causing alpha+-Thalassemia: Hb Nanning (HBA2: c.369_370delinsGA).
    Hemoglobin. 2017;41:56-58.
    PubMed     Text format     Abstract available


  60. JALILIAN M, Azizi Jalilian F, Ahmadi L, Amini R, et al
    The Frequency of HBB Mutations Among beta-Thalassemia Patients in Hamadan Province, Iran.
    Hemoglobin. 2017;41:61-64.
    PubMed     Text format     Abstract available


  61. CAPPABIANCA MP, Colosimo A, Sabatucci A, Dainese E, et al
    A Clinical Update of the Hb Siirt [beta27(B9)Ala-->Gly; HBB: c.83C>G] Hemoglobin Variant.
    Hemoglobin. 2017;41:53-55.
    PubMed     Text format     Abstract available


  62. EFTEKHARI H, Tamaddoni A, Mahmoudi Nesheli H, Vakili M, et al
    A Comprehensive Molecular Investigation of alpha-Thalassemia in an Iranian Cohort from Different Provinces of North Iran.
    Hemoglobin. 2017;41:32-37.
    PubMed     Text format     Abstract available


  63. YAVROPOULOU MP, Pikilidou M, Pantelidou D, Tsalikakis DG, et al
    Insulin Secretion and Resistance in Normoglycemic Patients with Sickle Cell Disease.
    Hemoglobin. 2017;41:6-11.
    PubMed     Text format     Abstract available


  64. LIN L, Chen B, Yi S, Chen Q, et al
    A Novel alpha2-Globin Gene Mutation: Hb Debao [alpha31(B12)Arg-->Trp; HBA2: c.94A>T].
    Hemoglobin. 2017;41:65-67.
    PubMed     Text format     Abstract available


  65. CARROCINI GCS, Venancio LPR, Pessoa VLR, Lobo CLC, et al
    Mutational Profile of Homozygous beta-Thalassemia in Rio de Janeiro, Brazil.
    Hemoglobin. 2017;41:12-15.
    PubMed     Text format     Abstract available


  66. LI Y, Yan JM, Zhou JY, Lu YC, et al
    Combination of Hb Heze [beta144(HC1)Lys-->Arg; HBB: c.434A>G] and beta0-Thalassemia in a Chinese Patient with beta-Thalassemia Intermedia.
    Hemoglobin. 2017;41:47-49.
    PubMed     Text format     Abstract available


    November 2016
  67. MAINOU M, Kotsiafti A, Klonizakis P, Soulountsi V, et al
    A Case of Fatal Agranulocytosis That Developed in a Patient with beta-Thalassemia Major Treated with Deferiprone.
    Hemoglobin. 2016;40:435-437.
    PubMed     Text format     Abstract available


  68. GORELLO P, Arcioni F, Palmieri A, Barbanera Y, et al
    The Molecular Spectrum of beta- and alpha-Thalassemia Mutations in Non-Endemic Umbria, Central Italy.
    Hemoglobin. 2016;40:371-376.
    PubMed     Text format     Abstract available


  69. LEE HH, Mak AS, Kou KO, Poon CF, et al
    An Unusual Hydrops Fetalis Associated with Compound Heterozygosity for Kruppel-like Factor 1 mutations.
    Hemoglobin. 2016;40:431-434.
    PubMed     Text format     Abstract available


  70. GARCIA-MORIN M, Lopez-Sanguos C, Vazquez P, Alvarez T, et al
    Lactate Dehydrogenase: A Marker of the Severity of Vaso-Occlusive Crisis in Children with Sickle Cell Disease Presenting at the Emergency Department.
    Hemoglobin. 2016;40:388-391.
    PubMed     Text format     Abstract available


  71. LAI Y, Chen Y, Chen B, Zheng H, et al
    Genetic Variants at BCL11A and HBS1L-MYB loci Influence Hb F Levels in Chinese Zhuang beta-Thalassemia Intermedia Patients.
    Hemoglobin. 2016;40:405-410.
    PubMed     Text format     Abstract available


  72. JIANG H, Yan JM, Zhou JY, Li DZ, et al
    Hb Alesha [beta67(E11)Val-->Met (GTG>ATG); HBB: c.202G > A] Found in a Chinese Girl.
    Hemoglobin. 2016;40:420-421.
    PubMed     Text format     Abstract available


  73. BHATTACHARYYA KK, Chatterjee T, Mondal UB
    A comprehensive screening program for beta-thalassemia and other hemoglobinopathies in the Hooghly District of West Bengal, India, dealing with 21 137 cases.
    Hemoglobin. 2016;40:396-399.
    PubMed     Text format     Abstract available


  74. KURTOGLU A, Karakus V, Erkal O, Kurtoglu E, et al
    beta-Thalassemia gene mutations in Antalya, Turkey: results from a single centre study.
    Hemoglobin. 2016;40:392-395.
    PubMed     Text format     Abstract available


  75. MEJRI A, Mansri M, Hadj Fredj S, Ouali F, et al
    First description of the rs45496295 polymorphism of the C/EBPE gene in beta-thalassemia intermedia patients.
    Hemoglobin. 2016;40:411-416.
    PubMed     Text format     Abstract available


  76. PULE GD, Ngo Bitoungui VJ, Chetcha Chemegni B, Kengne AP, et al
    Studies of novel variants associated with Hb F in Sardinians and Tanzanians in sickle cell disease patients from Cameroon.
    Hemoglobin. 2016;40:377-380.
    PubMed     Text format     Abstract available


  77. ZHAO L, Qing J, Liang Y, Chen Z, et al
    A novel compound heterozygosity in Southern China: IVS-II-5 (G > C) and IVS-II-672 (A > C).
    Hemoglobin. 2016;40:428-430.
    PubMed     Text format     Abstract available


  78. CHAN NC, Lau KM, Cheng KC, Chan NP, et al
    A Multi-locus Approach to Characterization of Major Quantitative Trait Loci Influencing Hb F Regulation in Chinese beta-thalassemia Carriers.
    Hemoglobin. 2016;40:400-404.
    PubMed     Text format     Abstract available


    September 2016
  79. JORGENSEN DR, Rosano C, Novelli EM
    Can Neuroimaging Markers of Vascular Pathology Explain Cognitive Performance in Adults with Sickle Cell Anemia? A Review of the Literature.
    Hemoglobin. 2016.
    PubMed     Text format     Abstract available


  80. GALLAGHER PG, Maksimova Y, Schulz VP, Forget BG, et al
    Mutation in a Highly Conserved COOH-Terminal Residue of Kruppel-Like Factor 1 Associated with Elevated Hb F in a Compound Heterozygous beta-Thalassemia Patient with a Nontransfusion-Dependent Thalassemia Phenotype.
    Hemoglobin. 2016;40:361-364.
    PubMed     Text format     Abstract available


  81. WAYE JS, Eng B, Hanna M, Hohenadel BA, et al
    Novel Mutation of the Translation Initiation Codon of the alpha1-Globin Gene (ATG>AAG or HBA1:c.2T>A).
    Hemoglobin. 2016;40:369-370.
    PubMed     Text format     Abstract available


  82. LIM YC, Tan KM, Chong SS, Rajendran J, et al
    A Patient with beta-Thalassemia Intermedia Secondary to Homozygosity for a Polyadenylation Signal Mutation (AATAAA > AATAGA) (HBB: C.*112A > G) on the beta-Globin Gene.
    Hemoglobin. 2016;40:359-360.
    PubMed     Text format     Abstract available


  83. PANJA A, Chowdhury P, Basu A
    Hb Midnapore [beta53(D4)Ala-->Val; HBB: c.161C>T]: A Novel Hemoglobin Variant with a Structural Abnormality Associated with IVS-I-5 (G>C) (HBB: c.92+5G>C) Found in a Bengali Indian Family.
    Hemoglobin. 2016;40:300-303.
    PubMed     Text format     Abstract available


  84. DERAKHSHAN SM, Khaniani MS, Afkhami F, PourFeizi AH, et al
    Molecular Study of Deletional and Nondeletional Mutations on the alpha-Globin Locus in the Azeri Population of Northwestern Iran.
    Hemoglobin. 2016;40:319-322.
    PubMed     Text format     Abstract available


  85. LOOVERS HM, Tamminga N, Mulder AB, Tamminga RY, et al
    Clinical Course of Two Children with Unstable Hemoglobins: The Effect of Hydroxyurea Therapy.
    Hemoglobin. 2016;40:341-344.
    PubMed     Text format     Abstract available


  86. YANG X, Yan JM, Li J, Xie XM, et al
    Hydrops Fetalis Associated with Compound Heterozygosity for Hb Zurich-Albisrieden (HBA2: C.178G > C) and the Southeast Asian (- -SEA/) Deletion.
    Hemoglobin. 2016;40:353-355.
    PubMed     Text format     Abstract available


  87. PULTE D, Lovett PB, Axelrod D, Crawford A, et al
    Comparison of Emergency Department Wait Times in Adults with Sickle Cell Disease Versus Other Painful Etiologies.
    Hemoglobin. 2016;40:330-334.
    PubMed     Text format     Abstract available


  88. YERUVA SL, Paul Y, Oneal P, Nouraie M, et al
    Renal Failure in Sickle Cell Disease: Prevalence, Predictors of Disease, Mortality and Effect on Length of Hospital Stay.
    Hemoglobin. 2016;40:295-299.
    PubMed     Text format     Abstract available


  89. ITALIA K, Dabke P, Sawant P, Nadkarni A, et al
    Hb E-beta-Thalassemia in Five Indian States.
    Hemoglobin. 2016;40:310-315.
    PubMed     Text format     Abstract available


  90. DING ZY, Shen GS, Zhang S, He PY, et al
    Epidemiology of Hemoglobinopathies in the Huzhou Region, Zhejiang Province, Southeast China.
    Hemoglobin. 2016;40:304-309.
    PubMed     Text format     Abstract available


  91. WARD R, Taha KM
    Patient Involvement as Experts in the Development and Assessment of a Smartphone App as a Patient Education Tool for the Management of Thalassemia and Iron Overload Syndromes.
    Hemoglobin. 2016;40:323-329.
    PubMed     Text format     Abstract available


  92. ZAREI T, Dehbozorgian J, Imanifard J, Setoodegan F, et al
    A Number of Cases in Iran Presenting with Coinheritance of Hemoglobin-H Disease and Beta-Thalassemia Minor.
    Hemoglobin. 2016;40:316-318.
    PubMed     Text format     Abstract available


  93. TORRES LS, Okumura JV, Belini-Junior E, Oliveira RG, et al
    Phenotypic Diversity of Sickle Cell Disease in Patients with a Double Heterozygosity for Hb S and Hb D-Punjab.
    Hemoglobin. 2016;40:356-358.
    PubMed     Text format     Abstract available


  94. WANG XY, Lin MX, Lin M
    A novel 6.3 kb deletion and the Rare 27.6 kb Deletion Causing alpha+-Thalassemia in two Chinese Patients.
    Hemoglobin. 2016;40:365-368.
    PubMed     Text format     Abstract available


  95. ORTS JA, Zuniga A, Bello Y, Fabregat AB, et al
    Hb A1c Determination by Capillary Electrophoresis is an Efficient Method for Detecting beta-Thalassemias and Hemoglobin Variants.
    Hemoglobin. 2016;40:335-340.
    PubMed     Text format     Abstract available


    August 2016
  96. DARVISHI KHEZRI H, Emami Zeydi A, Sharifi H, Jalali H, et al
    Is Vitamin C Supplementation in Patients with beta-Thalassemia Major Beneficial or Detrimental?
    Hemoglobin. 2016;40:293-4.
    PubMed     Text format     Abstract available


  97. SOLER AM, Schelotto M, de Oliveira Mota N, Dorta Ferreira R, et al
    The -(alpha)(5.2) Deletion Detected in a Uruguayan Family: First Case Report in the Americas.
    Hemoglobin. 2016;40:289-92.
    PubMed     Text format     Abstract available


  98. PONGJANTHARASATIEN K, Banyatsuppasin W, Pounsawat S, Jindadamrongwech S, et al
    Occurrence of the - -(SEA), - -(THAI) and - -(FIL) alpha-Thalassemia-1 Carriers from a 7-Year Study at Ramathibodi Hospital, Bangkok, Thailand.
    Hemoglobin. 2016;40:283-4.
    PubMed     Text format     Abstract available


  99. HE S, Lin L, Wei Y, Chen B, et al
    Identification of a Novel beta-Globin Mutation (HBB: C.189_195delTCATGGC) in a Chinese Family.
    Hemoglobin. 2016;40:277-9.
    PubMed     Text format     Abstract available


  100. YANG Y, Li DZ, He P
    A Program on Noninvasive Prenatal Diagnosis of alpha-Thalassemia in Mainland China: A Cost-Benefit Analysis.
    Hemoglobin. 2016;40:247-9.
    PubMed     Text format     Abstract available


  101. BILGEN T, Canatan D, Delibas S, Keser I, et al
    A Novel Mutation in the Promoter Region of the beta-Globin Gene: HBB: c.-127G > C.
    Hemoglobin. 2016;40:280-2.
    PubMed     Text format     Abstract available


  102. VINCIGUERRA M, Passarello C, Leto F, Crivello A, et al
    Coinheritance of a Rare Nucleotide Substitution on the beta-Globin Gene and Other Known Mutations in the Globin Clusters: Management in Genetic Counseling.
    Hemoglobin. 2016;40:231-5.
    PubMed     Text format     Abstract available


  103. YANG Y, Li DZ, He P
    Hb Dapu (HBA2: c.52G > T): A Novel Nondeletional alpha-Thalassemia Mutation.
    Hemoglobin. 2016;40:264-6.
    PubMed     Text format     Abstract available


  104. MEHER S, Dehury S, Mohanty PK, Patel S, et al
    Hb Tianshui (HBB: C.119A > G) in Compound Heterozygosity with Hb S (HBB: C.20A > T) from Odisha, India.
    Hemoglobin. 2016;40:270-2.
    PubMed     Text format     Abstract available


  105. KARIMI M, Jooya P, Haghpanah S, Mokhtari M, et al
    Evaluation of the Relationship Between Hb F Levels and Nucleated Red Blood Cells with Morbidity in Non Transfusion-Dependent Thalassemia Patients.
    Hemoglobin. 2016;40:250-6.
    PubMed     Text format     Abstract available


  106. SINGH MP, Gupta RB, Yadav R, Sharma RK, et al
    Prevalence of alpha(+)-Thalassemia in the Scheduled Tribe and Scheduled Caste Populations of Damoh District in Madhya Pradesh, Central India.
    Hemoglobin. 2016;40:285-8.
    PubMed     Text format     Abstract available


    June 2016
  107. BELISARIO AR, Sales RR, Silva CM, Velloso-Rodrigues C, et al
    The Natural History of Hb S/Hereditary Persistence of Fetal Hemoglobin in 13 Children from the State of Minas Gerais, Brazil.
    Hemoglobin. 2016;40:215-9.
    PubMed     Text format     Abstract available


  108. YAN JM, Zhou JY, Xie XM, Li J, et al
    A New delta-Globin Gene Variant: Hb A2-Fengshun [delta121(GH4)Glu-->Lys (HBD: c.364G > A)].
    Hemoglobin. 2016;40:213-4.
    PubMed     Text format     Abstract available


  109. BUI THI KIM L, Phu Chi D, Hoang Thanh C
    Spectrum of Common alpha-Globin Deletion Mutations in the Southern Region of Vietnam.
    Hemoglobin. 2016;40:206-7.
    PubMed     Text format     Abstract available


  110. JIANG H, Yan JM, Li J, Xie XM, et al
    Diagnostic Dilemma of Hb Perth [beta32(B14)Leu-->Pro; HBB: c.98T > C] in Mainland China.
    Hemoglobin. 2016;40:202-5.
    PubMed     Text format     Abstract available


  111. PARMEGGIANI G, Gualandi F, Selvatici R, Rimessi P, et al
    A Family with gamma-Thalassemia and High Hb A2 Levels.
    Hemoglobin. 2016;40:187-90.
    PubMed     Text format     Abstract available


  112. MIRI-MOGHADDAM E, Bahrami S, Naderi M, Bazi A, et al
    Molecular Characterization of beta-Thalassemia Intermedia in Southeast Iran.
    Hemoglobin. 2016;40:173-8.
    PubMed     Text format     Abstract available


  113. MUNKONGDEE T, Tanakulmas J, Butthep P, Winichagoon P, et al
    Molecular Epidemiology of Hemoglobinopathies in Cambodia.
    Hemoglobin. 2016;40:163-7.
    PubMed     Text format     Abstract available


  114. MAXIMO C, Olalla Saad ST, Thome E, Queiroz AM, et al
    Amputations in Sickle Cell Disease: Case Series and Literature Review.
    Hemoglobin. 2016;40:150-5.
    PubMed     Text format     Abstract available


  115. YUZBASIOGLU ARIYUREK S, Yildiz SM, Yalin AE, Guzelgul F, et al
    Hemoglobinopathies in the Cukurova Region and Neighboring Provinces.
    Hemoglobin. 2016;40:168-72.
    PubMed     Text format     Abstract available


  116. ZHENG CY, Minniti CP, Chaitowitz MH
    Sickle Cell Crisis Complicated by Synthetic Cannabinoid Abuse: A Case Report.
    Hemoglobin. 2016;40:220-2.
    PubMed     Text format     Abstract available


  117. DIVOKA M, Partschova M, Kucerova J, Mojzikova R, et al
    Molecular Characterization of beta-Thalassemia in the Czech and Slovak Populations: Mediterranean, Asian and Unique Mutations.
    Hemoglobin. 2016;40:156-62.
    PubMed     Text format     Abstract available


  118. ZHOU JY, Yan JM, Li J, Li DZ, et al
    First Case of a Compound Heterozygosity for Two Nondeletional alpha-Thalassemia mutations, Hb Constant Spring and Hb Quong Sze.
    Hemoglobin. 2016;40:210-2.
    PubMed     Text format     Abstract available


  119. HAN L, Su H, Wu H, Jiang W, et al
    Molecular Epidemiological Survey of Glucose-6-Phosphate Dehydrogenase Deficiency and Thalassemia in Uygur and Kazak Ethnic Groups in Xinjiang, Northwest China.
    Hemoglobin. 2016;40:179-86.
    PubMed     Text format     Abstract available


  120. LI J, Yan JM, Xie XM, Zhou JY, et al
    Consequences of Delayed Prenatal Diagnosis of beta-Thalassemia in Mainland China.
    Hemoglobin. 2016;40:191-3.
    PubMed     Text format     Abstract available


    January 2016
  121. WU MY, Li DZ
    The Codon 35 (A > G) (HBB: c.107A > G) at the alpha-beta Chain Interface of the beta-Globin Gene: A Silent Mutation?
    Hemoglobin. 2016;40:56-8.
    PubMed     Text format     Abstract available


  122. KORDAFSHARI A, Amirian A, Zeinali S, Valaei A, et al
    Molecular Characterization of delta-Thalassemia in Iran.
    Hemoglobin. 2016;40:44-7.
    PubMed     Text format     Abstract available


  123. GATIN L, Rogier de Mare A, Mary P, Vialle R, et al
    Osteonecrosis of the Femoral Head: A Proposed New Treatment in Homozygous Sickle Cell Disease.
    Hemoglobin. 2016;40:1-9.
    PubMed     Text format     Abstract available


  124. YANG Y, He P, Li DZ
    Analysis of Fetal Blood: Is There Still a Role for Prenatal Diagnosis of Thalassemia?
    Hemoglobin. 2016;40:29-31.
    PubMed     Text format     Abstract available


  125. GHARTEY-KWANSAH G, Boampong JN, Aboagye B, Afoakwah R, et al
    The Prevalence of alpha-Thalassemia and Its Relation to Plasmodium falciparum Infection in Patients Presenting to Clinics in Two Distinct Ecological Zones in Ghana.
    Hemoglobin. 2016;40:32-7.
    PubMed     Text format     Abstract available


  126. UGRIN M, Stojiljkovic M, Zukic B, Klaassen K, et al
    Functional Analysis of an (A)gamma-Globin Gene Promoter Variant (HBG1: g.-225_-222delAGCA) Underlines Its Role in Increasing Fetal Hemoglobin Levels Under Erythropoietic Stress.
    Hemoglobin. 2016;40:48-52.
    PubMed     Text format     Abstract available


  127. SURAPOLCHAI P, Sirachainan N, So CC, Hongeng S, et al
    Curative Stem Cell Transplantation for Severe Hb H Disease Manifesting From Early Infancy: Phenotypic and Genotypic Analyses.
    Hemoglobin. 2016;40:70-3.
    PubMed     Text format     Abstract available


  128. AU PK, Kan AS, Tang MH, Leung KY, et al
    A Fetus with Hb Bart's Disease Due to Maternal Uniparental Disomy for Chromosome 16.
    Hemoglobin. 2016;40:66-9.
    PubMed     Text format     Abstract available


  129. WU MY, Li DZ
    First Detection of the -27 (A > G) (HBB: c.-77A > G) Mutation of the beta-Globin Gene in a Chinese Family.
    Hemoglobin. 2016;40:59-60.
    PubMed     Text format     Abstract available


  130. FARASHI S, Vakili S, Garous NF, Ashki M, et al
    Identification of Mutations Causing Aberrant Termination and Deficient Splice Donor Site on the HBA1 Gene.
    Hemoglobin. 2016;40:38-43.
    PubMed     Text format     Abstract available


  131. SMITH DL, Mitui M, Park JY, Luu HS, et al
    Characterization of the HBB: c.*233G > C Variant: No Evidence of a beta-Thalassemic Phenotype.
    Hemoglobin. 2016;40:25-8.
    PubMed     Text format     Abstract available


  132. SILVA AN, Cardoso GL, Cunha DA, Diniz IG, et al
    The Spectrum of beta-Thalassemia Mutations in a Population from the Brazilian Amazon.
    Hemoglobin. 2016;40:20-4.
    PubMed     Text format     Abstract available


  133. AKINBAMI AO, Campbell AD, Han ZJ, Luo HY, et al
    Hereditary Persistence of Fetal Hemoglobin Caused by Single Nucleotide Promoter Mutations in Sickle Cell Trait and Hb SC Disease.
    Hemoglobin. 2016;40:64-5.
    PubMed     Text format     Abstract available


  134. SMELTZER MP, Nolan VG, Yu X, Nottage KA, et al
    Distance from an Urban Sickle Cell Center and its Effects on Routine Healthcare Management and Rates of Hospitalization.
    Hemoglobin. 2016;40:10-5.
    PubMed     Text format     Abstract available


  135. LI YQ, Ye LH, Mo Y
    Hb Matera (HBB: c.167 T > A): A Second Case Detected in a Pregnant Chinese Woman by the Capillary Electrophoresis Method.
    Hemoglobin. 2016;40:125-6.
    PubMed     Text format     Abstract available


  136. KHOSRAVI A, Jalali-Far M, Saki N, Hosseini H, et al
    Evaluation of alpha-Globin Gene Mutations Among Different Ethnic Groups in Khuzestan Province, Southwest Iran.
    Hemoglobin. 2016;40:113-7.
    PubMed     Text format     Abstract available


  137. ZHENG X, Lin M, Yang H, Pan MC, et al
    Molecular Epidemiological Characterization and Health Burden of Thalassemias in the Chaoshan Region, People's Republic of China.
    Hemoglobin. 2016;40:138-42.
    PubMed     Text format     Abstract available


  138. OLIVEIRA A, Warcel D, Huntley N, Eleftheriou P, et al
    Symptomatic Erythrocytosis Due to Homozygosity for Hb Luton [HBA2: c.269A>T (or HBA1)] and alpha-Thalassemia: A Clinical Update.
    Hemoglobin. 2016;40:127-9.
    PubMed     Text format     Abstract available


  139. FARASHI S, Rad F, Shahmohammadi B, Imanian H, et al
    First Report of a Dominantly Inherited beta-Thalassemia Caused by a Novel Elongated beta-Globin Chain.
    Hemoglobin. 2016;40:102-7.
    PubMed     Text format     Abstract available


  140. ALKHALDI SM, Khatatbeh MM, Berggren VE, Taha HA, et al
    Knowledge and Attitudes Toward Mandatory Premarital Screening Among University Students in North Jordan.
    Hemoglobin. 2016;40:118-24.
    PubMed     Text format     Abstract available


  141. CHERRY L, Calo C, Talmaci R, Perrin P, et al
    beta-Thalassemia Haplotypes in Romania in the Context of Genetic Mixing in the Mediterranean Area.
    Hemoglobin. 2016;40:85-96.
    PubMed     Text format     Abstract available


  142. COLLIER AB 3RD, Coon LM, Monteleone P, Umaru S, et al
    A Novel beta-Globin Chain Hemoglobin Variant, Hb Allentown [beta137(H15)Val-->Trp (GTG>TGG) HBB: c.412_413delinsTG, p.Val138Trp], Associated with Low Oxygen Saturation, Intermittent Aplastic Crises and Splenomegaly.
    Hemoglobin. 2016;40:130-3.
    PubMed     Text format     Abstract available


  143. HENDERSON SJ, Timbs AT, McCarthy J, Gallienne AE, et al
    Ten Years of Routine alpha- and beta-Globin Gene Sequencing in UK Hemoglobinopathy Referrals Reveals 60 Novel Mutations.
    Hemoglobin. 2016;40:75-84.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Anemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: